Health News
Anti-Cancer Combo: Caffeine + Exercise
Is coffee good for you or bad for you? More precisely, is caffeine helpful or hurtful to your health? It's been a steaming hot debate for years. A new study suggests that sipping away could nip away at your cancer risks.
Young Women Developing Melanoma
There's an alarming cancer trend. While other forms of the disease are decreasing, one type is going through the roof. Melanoma incidence is increasing in dramatic numbers among young people, and it is mostly preventable.
Melanoma Therapy Triggers Killing Machine
Using the perfected ability of viruses to infect cancer cells might strike some people as a cure worse than the disease. Despite that perception, this latest trend in cancer research has a lot of momentum behind it.
Speed Abating of Pre-Cancerous Condition
It's not skin cancer, but actinic keratosis (AK) is a condition that's headed in that direction. It can show up as one red, scaly spot or a number of lesions. And while there are a number of ways to treat AK, there are limitations, and a new prescription medication speeds up the process.
Advanced Melanoma may Soon Meet its Match
Melanoma, or the cancerous transformation of a mole, can be treated when caught early. Unfortunately, not all melanomas are visible, and those appearing underneath a fingernail or inside the mouth may escape notice until it's too late.
Making Alzheimer's a Better Memory
Could this dream come true? A medication that's currently approved for one disease could make Alzheimer's disease nothing more than a nightmarish memory.
Metastatic Melanoma Rx Increases Life Expectancy
Metastatic melanoma has a recently approved treatment option - Zelboraf ( vemurafenib ). That's the good news. The even better news is that recent research has discovered this medication extends the lives of patients taking it.
Roche’s Zelboraf Receives EU Approval for Treatment of Skin Cancer
Roche today announced that the European Commission has approved Zelboraf ( vemurafenib ) as a monotherapy for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, the most aggressive form of skin cancer.
Chemo That's Head and Neck Over Cancer
Doctors are always trying to find a competitive edge on any cancer, and finding new uses for current drugs is a common practice.
FDA Approves Advanced Basal Cell Cancer Drug
Roche announced that Erivedge ( vismodegib ) capsule was approved by the U.S. Food and Drug Administration (FDA) for adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.